NS · Pharmaceuticals

Sun Pharmaceutical Industries Ltd (SUNPHARMA)

Pharmaceuticals & Biotechnology

Sun Pharmaceutical Industries Ltd (SUNPHARMA) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $4.48T, P/E ratio is 170.81, net margin is 14.8%, dividend yield is 0.86%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for SUNPHARMA

Market cap
$4.48T
P/E ratio
170.81
Net margin
14.8%
Dividend yield
0.86%

Sun Pharmaceutical Industries Ltd (SUNPHARMA) — FAQ

What is Sun Pharmaceutical Industries Ltd's market cap?

Sun Pharmaceutical Industries Ltd (SUNPHARMA) has a reported market cap of $4.48T (data as of 2026-07-10).

What is SUNPHARMA's P/E ratio?

The price-to-earnings (P/E) ratio for Sun Pharmaceutical Industries Ltd (SUNPHARMA) is 170.81 (data as of 2026-07-10).

Does Sun Pharmaceutical Industries Ltd pay a dividend?

Sun Pharmaceutical Industries Ltd (SUNPHARMA) shows a reported dividend yield of 0.86%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).

What sector is Sun Pharmaceutical Industries Ltd in?

Sun Pharmaceutical Industries Ltd (SUNPHARMA) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).

What exchange is SUNPHARMA listed on?

SUNPHARMA is listed on NS.

What is Sun Pharmaceutical Industries Ltd's net margin?

Sun Pharmaceutical Industries Ltd (SUNPHARMA) reports a net margin of 14.8% (data as of 2026-07-10).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Pharmaceuticals companies

App Store Google Play